查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951269

微陣列分析市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品和服務、類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Microarray Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service, By Type, By Applications, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球微陣列分析市場預計將從 2025 年的 56.8 億美元成長到 2031 年的 92.3 億美元，複合年成長率為 8.43%。

微陣列分析是一種高通量技術，它利用固體基板上的雜合反應探針，可同時檢測基因表現或識別特定的DNA序列。市場擴張的主要驅動力是癌症和遺傳性疾病等慢性病的盛行率上升，這些疾病需要快速診斷篩檢。此外，對個人化醫療日益成長的需求以及藥物研發領域的大量投資也持續推動著產業成長，為其在基因組分析和臨床診斷領域的長期效用奠定了堅實的基礎。

市場概覽
預測期 2027-2031
市場規模：2025年 56.8億美元
市場規模：2031年 92.3億美元
複合年成長率：2026-2031年 8.43%
成長最快的細分市場 研究和學術機構
最大的市場 北美洲

然而，市場正面臨次世代定序技術的激烈競爭，這些技術解析度更高，成本效益也越來越高。隨著醫療系統努力應對日益成長的疾病負擔，這種競爭壓力尤其嚴峻。根據美國癌症協會預測，到2025年，美國將新增2,041,910例癌症病例，這意味著對基因組分析的巨大需求，而微陣列技術必須在滿足這一需求的同時，還要與更新、更先進的替代方案展開競爭。

市場促進因素

癌症和遺傳性疾病的日益普遍是推動微陣列分析技術應用的主要因素。隨著臨床醫生和研究人員致力於揭示惡性腫瘤複雜的遺傳基礎，微陣列為高通量基因表現分析和比較基因組雜合反應提供了重要的基礎。這項技術能夠快速識別生物標記和染色體異常，這對於早期檢測和疾病分型至關重要。根據國際癌症研究機構（IARC）2024年2月發布的新聞稿，全球癌症負擔日益加重，預計2022年全球將新增約2,000萬例癌症病例，並有970萬人死於癌症。這種情況凸顯了對強大的基因組分析工具的需求，以支持大規模人群篩檢和分子病理學研究，即便新的競爭技術不斷湧現。

同時，微陣列技術在藥物發現和開發領域的應用日益廣泛，顯著地推動了市場成長。製藥公司正廣泛利用這些平台進行標靶檢驗和毒理基因組學研究，從而在分子層面評估臨床前藥物的安全性和有效性，進而減少後期研發失敗，並簡化繁瑣的研發流程。歐洲製藥工業協會聯合會（EFPIA）2024年8月發布的報告也印證了推動這些活動的投資規模。該報告預測，2023年歐洲生物製藥產業的研發投入將達到500億歐元。此外，Illumina公司預計僅在2023會計年度，其微陣列業務的營收就將達到3.92億美元，反映了該技術持續的商業性可行性。

市場挑戰

來自次世代定序(NGS) 技術的日益激烈的競爭是全球微陣列分析市場成長的主要障礙。雖然微陣列提供了一個用於同時分析基因表現的平台，但它缺乏 NGS 的高解析度能力，而 NGS 能夠識別新的基因突變並進行更深入的基因組分析。隨著醫療機構將診斷準確性置於優先地位，兩種技術之間成本差距的縮小正在加速檢測量從微陣列向定序平台的轉移。這種替代效應限制了市場的潛在客戶群，使微陣列的應用範圍局限於小眾領域，而 NGS 則佔據了盈利的全球疾病譜分析市場。

近期產業應用數據也印證了這項技術變革的影響。根據美國病理學家協會 (CAP) 2024 年 11 月發布的一項臨床基因組報告實務調查顯示，所有受訪的腫瘤檢測均採用標靶基因組檢測，而非基於晶片的方法。這種在癌症診斷中對基於定序的工作流程的根深蒂固的偏好，表明更具效用的新技術正在直接蠶食微陣列技術在關鍵臨床應用中的市場佔有率。

市場趨勢

蛋白質微陣列在蛋白質體學研究中的快速發展，標誌著研究策略正從DNA分析轉向表現型表徵。高通量陣列使研究人員能夠解析僅憑基因組數據無法闡明的生物學機制，促進了其在大規模人群研究中的應用。這一趨勢在利用現代生物晶片多重分析能力的大規模生物銀行專案中尤為明顯。英國生物樣本庫在2025年1月發布的新聞稿中宣布啟動一項大規模蛋白質研究，該計劃檢測60萬個檢體中的多達5,400種蛋白質，凸顯了這項技術在生物標記發現和藥物研發中日益成長的重要性。

同時，微陣列工作流程與次世代定序(NGS) 的整合正在建構全面的多組體學解決方案。主要企業正將基於微陣列的親和性平台與定序基礎設施結合，從而實現基因組和蛋白質組的同步分析，提供比任何單一技術整體情況。近期的一些策略性舉措凸顯了這種整合趨勢，例如 Standard Biotools 在 2025 年 11 月發布的財報中提到，該公司已於 2025 年 6 月將其 SomaLogic 業務出售給 Illumina。此類交易表明，業界正致力於將微陣列技術與定序系統融合，以提高診斷準確性。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球微陣列分析市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品/服務分類（耗材、軟體/服務、設備）
    • 按類型（DNA微陣列、蛋白質微陣列等）
    • 按應用領域（藥物發現、疾病診斷、研究等）
    • 按最終用戶（研究/學術機構、製藥/生物技術公司、診斷實驗室、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美微陣列分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲微陣列分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區微陣列分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東與非洲微陣列分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲微陣列分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球微陣列分析市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Merck KGaA
  • GE Healthcare Technologies, Inc.
  • Danaher Corporation
  • Arrayit Corporation
  • Microarrays Inc.
  • Bio-Rad Laboratories Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24003

The Global Microarray Analysis Market is projected to grow from USD 5.68 Billion in 2025 to USD 9.23 Billion by 2031, registering a CAGR of 8.43%. Microarray analysis serves as a high-throughput technology that utilizes hybridization probes on a solid substrate to simultaneously detect the expression of thousands of genes or identify specific DNA sequences. The market's expansion is primarily driven by the rising prevalence of chronic diseases, such as cancer and genetic disorders, which necessitates rapid diagnostic screening. Furthermore, the burgeoning demand for personalized medicine and significant investments in pharmaceutical research for drug discovery continue to bolster industry growth, providing a solid foundation for long-term utility in genomic analysis and clinical diagnostics.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.68 Billion
Market Size 2031USD 9.23 Billion
CAGR 2026-20318.43%
Fastest Growing SegmentResearch and Academic Institutes
Largest MarketNorth America

However, the market confronts a significant challenge due to intense competition from Next-Generation Sequencing technologies, which offer higher resolution and are becoming increasingly cost-effective. This competitive pressure is particularly acute as healthcare systems strive to manage the growing disease burden. According to the American Cancer Society, 2,041,910 new cancer cases are projected to occur in the United States in 2025, indicating a massive demand for genomic profiling that microarrays must vie to fulfill against newer, more advanced alternatives.

Market Driver

The escalating prevalence of cancer and genetic disorders acts as a primary force propelling the adoption of microarray analysis. As clinicians and researchers strive to unravel the complex genetic underpinnings of malignancies, microarrays provide a critical platform for high-throughput gene expression profiling and comparative genomic hybridization. This technology facilitates the rapid identification of biomarkers and chromosomal aberrations essential for early detection and disease subtyping. According to the International Agency for Research on Cancer's February 2024 press release regarding the growing global cancer burden, there were approximately 20 million new cancer cases and 9.7 million deaths worldwide in 2022, necessitating robust genomic tools to support large-scale population screening and molecular pathology despite emerging competition.

Concurrently, the growing application of microarrays in pharmaceutical drug discovery and development is significantly fortifying market expansion. Pharmaceutical entities utilize these platforms extensively for target validation and toxicogenomics, enabling the assessment of drug safety and efficacy at the molecular level before clinical trials, which helps mitigate late-stage failures and streamlines the intensive R&D process. The scale of investment driving these activities is underscored by the European Federation of Pharmaceutical Industries and Associations' August 2024 report, which estimated that the research-based biopharmaceutical industry invested €50,000 million in R&D in Europe in 2023. Furthermore, Illumina, Inc. generated $392 million in revenue specifically from its microarray segment during fiscal year 2023, reflecting the sustained commercial viability of this technology.

Market Challenge

The intensified competition from Next-Generation Sequencing (NGS) technologies constitutes a formidable barrier to the growth of the Global Microarray Analysis Market. Although microarrays provide a platform for simultaneous gene expression analysis, they lack the high-resolution capabilities of NGS, which can identify novel genetic variants and provide deeper genomic insights. As healthcare providers prioritize diagnostic precision, the diminishing cost gap between these technologies is accelerating the migration of testing volumes from microarrays to sequencing platforms. This substitution effect restricts the market's addressable audience, confining microarrays to niche applications while NGS captures the lucrative segment of comprehensive disease profiling.

The impact of this technological shift is underscored by recent industry usage data. According to the College of American Pathologists, in November 2024, a study on clinical genomic reporting practices revealed that 100% of the reviewed oncology assays utilized targeted genomic panels rather than array-based methods. This entrenched preference for sequencing-based workflows in cancer diagnostics demonstrates how the superior utility of newer alternatives is directly eroding the market share of microarray technologies in critical clinical settings.

Market Trends

The rapid expansion of protein microarrays in proteomics research signifies a strategic shift beyond DNA analysis toward phenotypic characterization. Researchers utilizing high-throughput arrays can now decipher biological mechanisms that genomic data alone cannot reveal, driving adoption in large-scale population studies. This trend is exemplified by massive biobanking initiatives that leverage the multiplexing capabilities of modern biochips. According to a UK Biobank press release in January 2025 regarding the launch of a significant protein study, the organization announced a project to measure up to 5,400 proteins in each of 600,000 samples, highlighting the technology's growing centrality in biomarker discovery and drug development.

Concurrently, the integration of microarray workflows with Next-Generation Sequencing (NGS) is creating comprehensive multi-omic solutions. Key players are merging microarray-based affinity platforms with sequencing infrastructure to enable simultaneous interrogation of the genome and proteome, providing a holistic view of disease biology that isolated technologies cannot achieve. This consolidation is highlighted by recent strategic moves, such as Standard BioTools Inc.'s November 2025 financial results, which noted the sale of its SomaLogic business to Illumina, Inc. in June 2025. Such transactions illustrate the industry's push to unify microarray capabilities with sequencing ecosystems to enhance diagnostic precision.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Merck KGaA
  • GE Healthcare Technologies, Inc.
  • Danaher Corporation
  • Arrayit Corporation
  • Microarrays Inc.
  • Bio-Rad Laboratories Inc.

Report Scope

In this report, the Global Microarray Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microarray Analysis Market, By Product and Service

  • Consumable
  • Software and Service
  • Instruments

Microarray Analysis Market, By Type

  • DNA Microarrays
  • Protein Microarrays
  • others

Microarray Analysis Market, By Applications

  • Drug Discovery
  • Disease Diagnostic
  • Research Applications
  • others

Microarray Analysis Market, By End-User

  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • others

Microarray Analysis Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microarray Analysis Market.

Available Customizations:

Global Microarray Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microarray Analysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product and Service (Consumable, Software and Service, Instruments)
    • 5.2.2. By Type (DNA Microarrays, Protein Microarrays, others)
    • 5.2.3. By Applications (Drug Discovery, Disease Diagnostic, Research Applications, others)
    • 5.2.4. By End-User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Microarray Analysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service
    • 6.2.2. By Type
    • 6.2.3. By Applications
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microarray Analysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product and Service
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Applications
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Microarray Analysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product and Service
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Applications
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Microarray Analysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product and Service
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Applications
        • 6.3.3.2.4. By End-User

7. Europe Microarray Analysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Type
    • 7.2.3. By Applications
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microarray Analysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Applications
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Microarray Analysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Applications
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Microarray Analysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Applications
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Microarray Analysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Applications
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Microarray Analysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Applications
        • 7.3.5.2.4. By End-User

8. Asia Pacific Microarray Analysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Type
    • 8.2.3. By Applications
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microarray Analysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Applications
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Microarray Analysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Applications
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Microarray Analysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Applications
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Microarray Analysis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Applications
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Microarray Analysis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Applications
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Microarray Analysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Type
    • 9.2.3. By Applications
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microarray Analysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Applications
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Microarray Analysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Applications
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Microarray Analysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Applications
        • 9.3.3.2.4. By End-User

10. South America Microarray Analysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Type
    • 10.2.3. By Applications
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microarray Analysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Applications
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Microarray Analysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Applications
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Microarray Analysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Applications
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microarray Analysis Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Agilent Technologies Inc.
  • 15.3. Illumina Inc.
  • 15.4. PerkinElmer Inc.
  • 15.5. Merck KGaA
  • 15.6. GE Healthcare Technologies, Inc.
  • 15.7. Danaher Corporation
  • 15.8. Arrayit Corporation
  • 15.9. Microarrays Inc.
  • 15.10. Bio-Rad Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer